Looking to enhance your ultrasound knowledge and understanding beyond general abdominal exams?  Bootcamp Part 3: CARDIAC is an extension of our popular Veterinary Ultrasound courses, designed for the practitioner wishing to broaden their skills and imaging confidence into the world of ECHO ultrasound. 

Canine MMVD
The most recent ACVIM MMVD Consensus statement guidelines (2019) recommends initiation of treatment with pimobendan in Stage B2 MMVD. The definition of Stage B2 is based primarily on specific heart size and diagnosis of Stage B2 MMVS is now the recommended threshold for initiation of treatment with pimobendan in dogs with preclinical (Stage B) MMVD.

Echocardiography is the most sensitive method to measure heart size and is now the diagnostic test with the highest priority in dogs with preclinical MMVD.
This course will teach you how to acquire and accurately measure the left atrium and left ventricle using simple right parasternal 2D echocardiographic images allowing you to diagnose Stage B2 MMVD and recommend pimobendan treatment according to the 2019 ACVIM MMVD Consensus statement guidelines.

Feline Cardiomyopathy
The prevalence of feline cardiomyopathy is on average about 15% and increases with age. Many apparently healthy cats (20-50%) have heart murmurs, however many heart murmurs in cats are not pathologic. Thirty percent of cats with preclinical hypertrophic cardiomyopathy go on to develop congestive heart failure (20%) and/or arterial thromboembolism (10%).
The best method to discriminate pathologic from non-pathologic murmurs is echocardiographic assessment with emphasis on accurate assessment of left atrial size. Left atrial enlargement represents a known risk factor for the development of both congestive heart failure and arterial thromboembolism. In cats with active respiratory distress focused assessment of left atrial size can help support (left atria enlargement) or exclude (normal left atrial size) congestive heart failure.
This course will teach you how to acquire and accurately measure the left atrium using simple right parasternal 2D echocardiographic images allowing you to stage the severity of cardiomyopathy.

Dates

September 19 – 21, 2024, September 29 – October 1st, 2023